Literature DB >> 15364998

Correlation of wbiI genotype, serotype, and isolate source within species of the Burkholderia cepacia complex.

Arlene D Vinion-Dubiel1, Theodore Spilker, Charles R Dean, Henri Monteil, John J LiPuma, Joanna B Goldberg.   

Abstract

Gram-negative bacteria of the Burkholderia cepacia complex (Bcc) are opportunistic pathogens that can infect the lungs of cystic fibrosis (CF) patients and can be transmitted among these patients, causing epidemics in the CF community. Lipopolysaccharide (LPS) is an important virulence factor of many gram-negative bacteria, with the O antigen component of LPS being responsible for serotype specificity. The goal of this work was to develop a genetic method of determining the serotype of Bcc isolates based on the conserved gene wbiI. Homologues of wbiI are found in polysaccharide biosynthesis gene clusters in other bacteria. Primers to a conserved region of the Bcc wbiI gene were able to amplify by PCR a single product in 67 of 80 Bcc isolates tested. Sequencing and restriction enzyme digestion of this wbiI PCR product revealed sufficient DNA polymorphisms to distinguish and group various isolates. In five of nine instances, Bcc isolates of a single serotype had a single wbiI restriction fragment length polymorphism (RFLP) pattern, while isolates of the other four serotypes could have multiple wbiI RFLP types. Species determination of the Bcc isolates revealed no obvious correlation between wbiI RFLP type and species. There was also no apparent correlation between wbiI RFLP type and the ability of a single Bcc isolate to infect an individual with CF. However three of five Bcc outbreaks involved isolates with the same wbiI RFLP type, indicating that wbiI RFLP typing may be a useful tool to help track Bcc outbreaks.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15364998      PMCID: PMC516295          DOI: 10.1128/JCM.42.9.4121-4126.2004

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

Review 1.  Genomic organization of LPS-specific loci.

Authors:  P P Reeves; L Wang
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

2.  Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis.

Authors:  J J LiPuma; T Spilker; L H Gill; P W Campbell; L Liu; E Mahenthiralingam
Journal:  Am J Respir Crit Care Med       Date:  2001-07-01       Impact factor: 21.405

3.  Lack of correlation between O-serotype, bacteriophage susceptibility and genomovar status in the Burkholderia cepacia complex.

Authors:  Dervla T Kenna; Victoria A Barcus; Ross J Langley; Peter Vandamme; John R W Govan
Journal:  FEMS Immunol Med Microbiol       Date:  2003-03-20

4.  DNA-Based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III.

Authors:  E Mahenthiralingam; J Bischof; S K Byrne; C Radomski; J E Davies; Y Av-Gay; P Vandamme
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

5.  Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.

Authors:  P Vandamme; B Holmes; M Vancanneyt; T Coenye; B Hoste; R Coopman; H Revets; S Lauwers; M Gillis; K Kersters; J R Govan
Journal:  Int J Syst Bacteriol       Date:  1997-10

6.  O and H serotyping of Pseudomonas cepacia.

Authors:  A Heidt; H Monteil; C Richard
Journal:  J Clin Microbiol       Date:  1983-09       Impact factor: 5.948

7.  The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain.

Authors:  L Sun; R Z Jiang; S Steinbach; A Holmes; C Campanelli; J Forstner; U Sajjan; Y Tan; M Riley; R Goldstein
Journal:  Nat Med       Date:  1995-07       Impact factor: 53.440

8.  Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping.

Authors:  W M Johnson; S D Tyler; K R Rozee
Journal:  J Clin Microbiol       Date:  1994-04       Impact factor: 5.948

9.  Evidence of transmission of Burkholderia cepacia, Burkholderia multivorans and Burkholderia dolosa among persons with cystic fibrosis.

Authors:  Rhiannon Biddick; Theodore Spilker; Alissa Martin; John J LiPuma
Journal:  FEMS Microbiol Lett       Date:  2003-11-07       Impact factor: 2.742

10.  The relationship of phenotype changes in Pseudomonas aeruginosa to the clinical condition of patients with cystic fibrosis.

Authors:  A Penketh; T Pitt; D Roberts; M E Hodson; J C Batten
Journal:  Am Rev Respir Dis       Date:  1983-05
View more
  3 in total

Review 1.  Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.

Authors:  Alex Horsley; Andrew M Jones; Robert Lord
Journal:  Cochrane Database Syst Rev       Date:  2016-01-20

2.  Phylogeographic, genomic, and meropenem susceptibility analysis of Burkholderia ubonensis.

Authors:  Erin P Price; Derek S Sarovich; Jessica R Webb; Carina M Hall; Sierra A Jaramillo; Jason W Sahl; Mirjam Kaestli; Mark Mayo; Glenda Harrington; Anthony L Baker; Lindsay C Sidak-Loftis; Erik W Settles; Madeline Lummis; James M Schupp; John D Gillece; Apichai Tuanyok; Jeffrey Warner; Joseph D Busch; Paul Keim; Bart J Currie; David M Wagner
Journal:  PLoS Negl Trop Dis       Date:  2017-09-14

3.  Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.

Authors:  Robert Lord; Andrew M Jones; Alex Horsley
Journal:  Cochrane Database Syst Rev       Date:  2020-04-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.